A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of efficacy in a small pilot trial involving patients with lymphoma of the brain and/or spinal cord, ...

Researchers said the treatment regimen was more effective in lymphoma patients whose disease had already spread to the brain or spine. Sign up for the top news stories every day to keep you informed ...